| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT03419234 Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone… |
date change Completion pushed: 2026-04-01 -> 2028-04-01 |
| 2026-05-28 | NCT04239573 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated… |
Phase changed: ['NA'] -> [] |
| 2026-05-28 | NCT04239573 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated… |
Primary endpoint(s) modified |
| 2026-05-28 | NCT04239573 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated… |
Enrollment reduced: 4606 -> 770 participants |
| 2026-05-28 | NCT04239573 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated… |
Trial arms changed: 2 -> 3 |
| 2026-05-28 | NCT04239573 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated… |
date change Primary completion moved earlier: 2037-06-03 -> 2030-12-31 |
| 2026-05-28 | NCT04239573 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated… |
date change Completion moved earlier: 2037-06-03 -> 2031-12-31 |
| 2026-05-16 | NCT04423211 Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted… |
Trial sites expanded: 303 -> 342 locations |
| 2026-05-16 | NCT04239573 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated… |
Trial sites expanded: 352 -> 424 locations |
| 2026-05-16 | NCT06475989 Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer |
Trial sites expanded: 112 -> 301 locations |
| 2026-05-16 | NCT06295367 Cost Communication and Financial Navigation in Cancer Patients (COSTCOM) |
Trial sites expanded: 181 -> 392 locations |
| 2026-05-16 | NCT06112613 Mobile Health for Adherence in Breast Cancer Patients |
Trial sites expanded: 400 -> 506 locations |
| 2026-05-16 | NCT03937635 Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With… |
Trial sites expanded: 707 -> 747 locations |
| 2026-05-16 | NCT07001748 Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With… |
Trial sites expanded: 10 -> 55 locations |
| 2026-05-16 | NCT06319027 Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain… |
Trial sites expanded: 1 -> 12 locations |
| 2026-05-16 | NCT05863195 Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of… |
Trial sites expanded: 39 -> 60 locations |
| 2026-05-16 | NCT02734537 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA… |
Trial sites expanded: 640 -> 676 locations |
| 2026-05-16 | NCT04566328 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple… |
Trial sites expanded: 600 -> 649 locations |
| 2026-05-15 | NCT04462406 Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With… |
date change Primary completion pushed: 2026-08-29 -> 2027-01-31 |
| 2026-05-15 | NCT04462406 Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With… |
date change Completion pushed: 2026-08-29 -> 2030-09-30 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT03937635 | Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With… | Smoldering Plasma Cell Myeloma | Recruiting |
| NCT04423211 | Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted… | Biochemically Recurrent Prostate Carcinoma | Recruiting |
| NCT04566328 | Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple… | Plasma Cell Myeloma | Recruiting |
| NCT06475989 | Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer | Refractory Differentiated Thyroid Gland Carcinoma | Recruiting |
| NCT05863195 | Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of… | Metastatic Colorectal Carcinoma | Recruiting |
| NCT00003641 | High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma | Melanoma (Skin) | Active, Not Recruiting |
| NCT03233191 | Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for… | Breast Screening | Active, Not Recruiting |
| NCT03267433 | Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual… | Mantle Cell Lymphoma | Active, Not Recruiting |
| NCT04248452 | Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients… | Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 | Active, Not Recruiting |
| NCT04484818 | Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy… | Prostate Carcinoma | Active, Not Recruiting |
| NCT05538663 | Intravesical BCG vs GEMDOCE in NMIBC | Non-muscle-invasive Bladder Cancer | Active, Not Recruiting |
| NCT05721755 | Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous… | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Active, Not Recruiting |
| NCT05863351 | Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited… | Metastatic Renal Cell Carcinoma | Active, Not Recruiting |
| NCT02445391 | Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following… | Estrogen Receptor Negative | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07001748 | Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With… | Gastric Adenocarcinoma | Recruiting |
| NCT04559139 | Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the… | Stage II Gallbladder Cancer AJCC v8 | Active, Not Recruiting |
| Phase 2 | |||
| NCT03493425 | Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone… | Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 | Recruiting |
| NCT02734537 | Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA… | Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT06319027 | Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain… | Glioblastoma, IDH-Wildtype | Recruiting |
| NCT01824875 | Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic… | Gastrinoma | Active, Not Recruiting |
| NCT01898494 | Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without… | Human Papilloma Virus Infection | Active, Not Recruiting |
| NCT03516279 | Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With… | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Active, Not Recruiting |
| NCT02595424 | Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced… | Gastric Neuroendocrine Carcinoma | Active, Not Recruiting |
| NCT04115631 | A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly… | Liver Lymphoma | Active, Not Recruiting |
| NCT04166318 | Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE… | Anal Basaloid Carcinoma | Active, Not Recruiting |